Completed PHASE1 INTERVENTIONAL 4-arm NCT00548678

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

Open-Label, Randomized, Single-Dose, Four-Treatment Crossover Study to Evaluate Platelet Function in Healthy Adult Males After Administration of IV Diclofenac Sodium, Oral Diclofenac Potasssium, IV Ketorolac Tromethamine, and Acetylsalicylic Acid

Sponsor: Javelin Pharmaceuticals

Conditions Healthy

Interventions aspirin intravenous diclofenac sodium (DIC075V) ketorolac oral diclofenac (Cataflam)

Updated 6 times since 2017 Last updated: Jul 15, 2008 Started: Oct 31, 2007 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00548678, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Javelin Pharmaceuticals, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Javelin Pharmaceuticals

Data source: Javelin Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Miramar, United States